Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Licensing opportunity from the NIH: antiinflammatory cytokine

March 4, 1999

Placebo-controlled study supports the efficacy of Alrex in seasonal allergic conjunctivitis

March 1, 1999

Worldwide strategic alliance established by Agennix and Santen for lactoferrin

Feb. 26, 1999

Novel antioxidant/antiproliferative NSAID esters and amides designed by Alcon

Feb. 19, 1999

CoCensys enters research agreements with Senju and Parke-Davis

Feb. 18, 1999

FDA says KeraVision's treatment for myopia approvable

Feb. 17, 1999

Patient enrollment completed in loteprednol/antibiotic combination study

Feb. 11, 1999

Sunrise LTK System PMA accepted for filing by FDA

Feb. 11, 1999

Emadine approved for conjunctivitis in Europe

Feb. 8, 1999

InSite Vision licenses novel glaucoma treatment to Pharmacia & Upjohn

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....